Abstract | BACKGROUND/AIMS: We aimed to detect the distribution of DNA repair genes XRCC1 and XRCC3 genotypes in the survival of colorectal cancer patients receiving chemotherapy in the Chinese population. METHODOLOGY: The prospective study was conducted with 432 cases treated with 5-FU and oxaliplatin as first-line chemotherapy. All the patients were followed-up from May 2006 to May 2011 and 168 patients died during follow-up. XRCC1 and XRCC3 genotype polymorphisms were based upon the PCR-CTPP method. RESULTS: It was shown that the XRCC1 Arg399Gln and XRCC3 Thr241Met gene polymorphisms were associated with increased death risk of colorectal cancer. Individuals carrying XRCC1 Gln/Gln, Thr/Met and Met/Met genotypes positively associated with 2.78-, 2.86- and 3.0-fold death risk of colorectal cancer. Moreover, the combination of XRCC1 399Gln allele and XRCC3 241Met allele showed a significantly strong association with death risk of colorectal cancer (OR=3.46, 95%CI=1.65- 5.48). CONCLUSIONS:
|
Authors | Yang Liu, Haihui Chen, Limin Chen, Chunhong Hu |
Journal | Hepato-gastroenterology
(Hepatogastroenterology)
Vol. 59
Issue 116
Pg. 977-80
(Jun 2012)
ISSN: 0172-6390 [Print] Greece |
PMID | 22580644
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- DNA-Binding Proteins
- Organoplatinum Compounds
- X-ray Repair Cross Complementing Protein 1
- X-ray repair cross complementing protein 3
- XRCC1 protein, human
- Oxaliplatin
- Fluorouracil
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Biomarkers, Tumor
(genetics)
- Colorectal Neoplasms
(drug therapy, genetics, mortality)
- DNA Repair
- DNA-Binding Proteins
(genetics)
- Female
- Fluorouracil
(administration & dosage)
- Humans
- Male
- Middle Aged
- Organoplatinum Compounds
(administration & dosage)
- Oxaliplatin
- Polymorphism, Genetic
- Prospective Studies
- X-ray Repair Cross Complementing Protein 1
|